Liver Cancer Clinical Trials in Seoul
6 recruitingSeoul, South Korea
Showing 1–6 of 6 trials
Recruiting
Phase 1
A Study to Test Different Doses of BI 765049 Alone and in Combination With Ezabenlimab in Asian People With Advanced Cancer (Solid Tumours) Positive for B7-H6
Liver CancerColorectal, CancerPancreatic Cancer+3 more
Boehringer Ingelheim97 enrolled7 locationsNCT06091930
Recruiting
Phase 1Phase 2
A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Liver)
Advanced Liver Cancers
Hoffmann-La Roche518 enrolled33 locationsNCT04524871
Recruiting
Streamlining Radioembolization for CCC and Metastatic Liver Cancer
CholangiocarcinomaMetastatic Liver CancerMetastatic Colorectal Carcinoma (mCRC)
Seoul National University Hospital60 enrolled4 locationsNCT07043387
Recruiting
Phase 2
Atezolizumab Plus Bevacizumab Alone or Combined with External Beam Radiotherapy for HCC with Macrovascular Invasion
Liver CancerHepatocellular CarcinomaHepatocellular Cancer+2 more
Asan Medical Center138 enrolled1 locationNCT05992220
Recruiting
Phase 2
TACE Using Idarubicin Versus Doxorubicin Chemoemulsion in Patients with Hepatocellular Carcinoma
Liver CancerHepatocellular Carcinoma
Seoul National University Hospital128 enrolled1 locationNCT06114082
Recruiting
Phase 1
A Safety and Efficacy Study of Multiple Tyrosine Kinase Inhibitor Drug (ETN101) in Advanced Hepatocellular Carcinoma
Liver CancerHepatocellular CarcinomaAdvanced Hepatocellular Carcinoma
Etnova Therapeutics Corp.50 enrolled2 locationsNCT06326502